Track the 대한약품 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 대한약품 has recorded 140 reports. The latest transaction was reported on 31 August 2026 (Purchase). Among the most active insiders: 이윤우. All data is accessible without an account.
140
Insider Decl.
n/a
Thresholds
€15,521
63 ops.
Buy Volume
n/a
2 ops.
Sell Volume
22Σ signal
Buys €15,521n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
